Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: a safety meta-analysis of randomised controlled trials and a retrospective study of the WHO pharmacovigilance database

Authors: Pierre‐Marie Morice, Alexandra Léary, Charles Dolladille, Basile Chrétien, Laurent Poulain, Antonio González-Martı́n, Kathleen N. Moore, Eileen M. O’Reilly, Isabelle Ray‐Coquard, Joachim Alexandre - The Lancet 2020 cited by 244